Mamatech, Meablex, Optosleep, and Pulsatile Named Finalists in 2025 BBFH Challenge

Mamatech, founded in 2025 by two women’s health physiotherapists, is an early-stage Western Australian med-tech startup developing Mamawand, the world’s first personal handheld consumer-grade therapeutic ultrasound device for breastfeeding women, which is specifically designed to treat inflammatory conditions of the lactating breast such as mastitis, blocked ducts, and engorgement, thereby providing an accessible and effective at-home solution that empowers women and improves postnatal care.

Meablex is transforming prosthetic technology through the development of a sensorised quick-fit prosthetic socket integrated with its novel AI-powered MyoLog sensing system, thereby overcoming the limitations of traditional electromyography-based control, which is often prone to noise, perspiration, muscle fatigue, and poor electrode placement, factors that contribute to high rejection rates, particularly among children, while simultaneously eliminating the need for frequent and costly custom sockets as users grow, thus improving accessibility, comfort, and long-term usability.

OptoSleep is addressing the significant global challenge of obstructive sleep apnoea, a condition that affects up to a billion people worldwide, by creating a smart oral appliance that delivers light stimulation to throat muscles to trigger contraction and maintain airway openness during sleep, while also integrating an algorithm to automate patient-specific appliance design for 3D printing, refining sensor analysis and stimulation algorithms, and incorporating machine learning for efficacy monitoring and performance validation within the device hardware, thereby advancing toward a highly personalised and non-invasive therapeutic solution.

Finally, Pulsatile Innovations extends this wave of healthcare transformation with PulseTile, a single-use sensing device designed to be applied to the neck of a person in suspected cardiac arrest, which enables rescuers to rapidly detect the presence or absence of a pulse and determine whether life-saving interventions such as cardiopulmonary resuscitation are required, thus enhancing decision-making and improving outcomes in critical emergency situations.